Phenomenal 'debate' session highlighting the challenges in IMDC favorable risk, and strategies for choosing a comparator arm for future trials. Tremendously thoughtful discussions from Cris Ignacio Duran Martin Voss and Dr. Bernard Escudier #IKCSEU24 Kidney Cancer

APCCC debate with Thomas Zilli and Pierre Blanchard covering radiation therapy for metastatic disease from Lugano. Thanks to Neeraj Agarwal, MD, FASCO for help with the tweet. #APCCC2024 OncoAlert . t.ly/D7N0_

Europe emphasized program implementation for patient and organization support - Yuksel Urun
Ankara Üniversitesi Kidney Cancer Michael Staehler
Salvatore La Rosa Laurence Albiges Cris Dena Battle Ignacio Duran IKCC Kidney Cancer

#Cancer #OncoDaily #Oncology #PatientAdvocacy

oncodaily.com/54796.html

Updated 1st-line treatment in mRCC!
Kidney Cancer Michael Staehler Salvatore La Rosa
Laurence Albiges Cris Dena Battle Ignacio Duran #IKCSEU24 #Oncology #Cancer Gretchen Vaughan OncoAlert KidneyCAN Uromigos UroToday.com Maite Bourlon

Thanks to the KCA team for their steadfast support, the entire scientific committee and all the speakers for their outstanding contribution. Thank you for making an amazing #IKCSEU24  
Kidney Cancer Vall d’Hebron Institute of Oncology (VHIO)

We had a great day ahead of the #IKCSEU24 main program, discussing key needs in #kidneycancer research at the Think Tank, a surgery-focused workshop for young clinicians, and faculty reception. Thanks to our early attendees and we look forward to seeing everyone tomorrow!

And we are off! Cris introducing #IKCSEU24
Breakfast session featuring Tom Powles - apparently an oxymoron! Brian Rini, MD Arnaud Méjean, MD, PhD Axel Bex, Lars Lund

Turajlic Lab @ The Crick Cris Tom Powles Brian Rini, MD Arnaud Méjean, MD, PhD Missing my #kidneycancer family! Wishing you all a great meeting!

Updated data with lenvatinib and Pembrolizumab in 158 1st line advanced non-clear cell renal cancer #ikcs24 . 8 mnths extra FU. RR= 50% seems higher than sunitinib. 18 month mPFS and 80% 12 month OS also looks ⬆️, but randomised trials such as SAMETA and XL92/nivo remain important

Congratulations to Dr. Bernard Escudier on receiving the Nicholas J. Vogelzang Humanitarian Award at the 2024 International Kidney Cancer Symposium. His dedication to medical oncology and humanitarian efforts,patient advocacy are truly inspirational and deserving of this…

Wonderful few days of amazing friends, the brightest minds, transformative research all in beautiful sitges spain 🇪🇸🧡💚 #unstoppabletogether #IKCS24 Salvatore La Rosa Kidney Cancer Cris Laurence Albiges Brian Rini, MD Tom Powles James Brugarolas Michael Staehler B.C. Leibovich MD

Experts unite at the 2024 Kidney Cancer Symposium to tackle kidney cancer together. #IKCS2024 #TogetherAgainstCancer
Kidney Cancer Michael Staehler Salvatore La Rosa Laurence Albiges Cris Dena Battle Ignacio Duran #IKCSEU24 #Oncology #Cancer Daniel Heng Turajlic Lab @ The Crick…

Can’t wait to see u all!!

6 Deep messages about life:

1.

What about Spain 🇪🇸? AEMPS Ministerio de Sanidad Fed. Nac. ALCER oficial SOGUG Asociación Española Contra el Cáncer SEOM

More evidence that ICI after ICI may not be effective. This is real-world evidence to complement CONTACT-3 trial from Sumanta K. Pal, MD, FASCO et al in The Lancet

Strong work Georges Gebrael Neeraj Agarwal, MD, FASCO Umang Swami

“Libertad no es fumar en una terraza, es poder disfrutarla sin humo”. Las principales sociedades médicas y organizaciones en la lucha contra el tabaco respaldan el plan del Ministerio de Sanidad. ⁦Grupo Español de Cáncer de Pulmón⁩ ⁦SEOM⁩ ⁦Asociación Española Contra el Cáncer LUGO⁩ elpais.com/sociedad/2024-…

📣 International Kidney Cancer Symposium: Europe 2024 ‼️

🗓️ 18-20 April, 2024
📍 Sitges, Spain

Co-Chairs: Lars Lund & Cris
Registration now open! 👇 👇
linke.to/2024IKCSVHIO

El Ministerio de Sanidad no financia terapias combinadas en cáncer renal necesarias y que cuestan vidas. Desde SOGUG nos sumamos a esta campaña de Fed. Nac. ALCER oficial de recogida de firmas para la aprobación de terapias que aumentan supervivencia global 👇👇
chng.it/Zstn9pGpFB

Se habla poco de la violencia estética...